Back to search

Peptide record

TPDB20282

Antibacterial Anticancer standard
13 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB20282
Antibacterial Anticancer
Anti-infective peptides Cancer-related peptides
Peptipedia
standard
No
A 13-aa standard-residue multi-activity (Antibacterial and Anticancer) peptide sequence curated from Peptipedia, with an available 3D structural model.
Sequence
GLFKIISKLAKKA
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C68H121N17O15
RNDCEQHMPTWYV
K
1416.81
11.00
4
0
7
+4
-0.12
0.477
135.38
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
0
0.00
1
Residue Composition
number
2
A
0
R
0
N
0
D
0
C
0
E
0
Q
1
G
0
H
2
I
2
L
4
K
0
M
1
F
0
P
1
S
0
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 2 R: 0 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 1 H: 0 I: 2 L: 2 K: 4 M: 0 F: 1 P: 0 S: 1 T: 0 W: 0 Y: 0 V: 0
Chemical Descriptors
13 reviewed residue count
C68H121N17O15 sequence-only estimate (linear, free termini)
1416.81 sequence-only estimate (linear, free termini)
11.00 sequence-only estimate (linear, free termini)
+4 sequence-only estimate (linear, free termini)
-0.12 sequence-only estimate (linear, free termini)
0.477 sequence-only estimate (linear, free termini)
Evidence Records 1 records
Evidence 1 Activity

Source & Reference

NA